Protective role of heme oxygenase in the blood vessel wall during atherogenesis

Biochemistry and Cell Biology

Volumn 82, Issue 3, 2004, Pages 351-359

  Hoekstra, Kenneth A ^a,c   Godin, David V ^b   Cheng, Kimberly M ^a  

^a Faculty of Science   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LANGARA COLLEGE   (Canada)

Author keywords

Antioxidant enzymes; Atherosclerosis; Gene therapy; Heme oxygenase; Oxidized LDL

Indexed keywords

ANTIOXIDANTS; BLOOD VESSELS; CARBON MONOXIDE; CATALYSIS; GENES; IRON; OXYGENATORS;

BILIRUBIN; HEME OXYGENASE (HO); MUSCLE CELL CULTURES; OXIDATIVE STRESS;

ENZYMES;

BILIRUBIN; BILIVERDIN; CARBON MONOXIDE; FERRITIN; HEME; HEME OXYGENASE; HEME OXYGENASE 1; IRON; OXIDIZED LOW DENSITY LIPOPROTEIN;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; CELL PROTECTION; CYTOTOXICITY; DISEASE SEVERITY; ENDOTHELIUM CELL; ENZYME DEFICIENCY; ENZYME INDUCTION; GENE THERAPY; GENETIC MODEL; HUMAN; IRON TRANSPORT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RABBIT; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASODILATATION;

ANIMALS; ANTIOXIDANTS; ARTERIOSCLEROSIS; BILIRUBIN; BILIVERDINE; BLOOD VESSELS; CARBON MONOXIDE; ENDOTHELIUM, VASCULAR; FERRITINS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE THERAPY; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; ISOENZYMES; LIPOPROTEINS, LDL; OXIDATIVE STRESS;

MURINAE; ORYCTOLAGUS CUNICULUS;

EID: 3843090635     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o04-006     Document Type: Short Survey

References (108)

1. Agarwal, A., Balla, J., Balla, G., Croatt, A.J., Vercellotti, G.M., and Nath, K.A. 1996. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am. J. Physiol. 271: F814-F823.
2. Agarwal, A., Shiraishi, F., Visner, G.A., and Nick, H.S. 1998. Linoleyl hydroperoxide transcriptionally upregulates heme oxygenase-1 gene expression in human renal epithelial and aortic endothelial cells. J. Am. Soc. Nephr. 9: 1990-1997.
3. Alam, J., and Den, Z. 1992. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J. Biol. Chem. 267: 21 894-21 900.
4. Amersi, F., Buelow, R., Kato, H., Ke, B., Coito, A.J., et al. 1999. Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J. Clin. Investig. 104: 1631-1639.
5. Amit, Y., and Boneh, A. 1993. Bilirubin inhibits protein kinase C activity and protein kinase C-mediated phosphorylation of endogenous substrates in human skin fibroblasts. Clin. Chim. Acta 223: 103-111.
6. Aviram, M. 2000. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic. Res. 33: S85-S97.
7. Balla, G., Jacob, H.S., Balla, J., Rosenberg, M., Nath, K., Apple, F., Eaton, J.W., and Vercellotti, G.M. et al. 1992. Perritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267: 18 148-18 153.
8. Balla, J., Jacob, H.S., Balla, G., Nath, K.A., Eaton, J.W., and Vercellotti, G.M. 1993. Endothelial-cell heme uptake from heme proteins: Induction of sensitization and desensitization to oxidant damage. Proc. Natl. Acad. Sci. U.S.A. 90: 9285-9289.
9. Berliner, J.A., and Heinecke, J.W. 1996. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20: 707-727.
10. Brown, M.S., and Goldstein, J.L. 1983. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Ann. Rev. Biochem. 52: 223-261.
11. Brown, M.S., Basu, S.K., Falck, J.R., Ho, Y.K., and Goldstein, J.L. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13: 67-81.
12. Chi, S.I., Wang, C.K., Chen, J.J., Chau, L.Y., Lin, T.N. 2000. Differential regulation of H- and L-ferritin messenger RNA sub-units, ferritin protein and iron following focal cerebral ischemia-reperfusion. Neuroscience, 100: 475-484.
13. Dalton, T., Palmiter, R.D., and Andrews, G.K. 1994. Transcriptional induction of the mouse metallothionein-I gene in hydrogen peroxide-treated Hepa cells involves a composite major late transcription factor/antioxidant response element and metal response promoter elements. Nucleic Acids Res. 22: 5016-5023.
14. Daugherty, A. 2002. Mouse models of atherosclerosis. Am. J. Med. Sci. 323: 3-10.
15. Duckers, H.J., Boehm, M., True, A.L., Yet, S.F., San, H., Park, J.L., Clinton, R., Lee, M.E., Nabel, G.J., and Nabel, E.G. et al. 2001. Heme oxygenase-1 protects against vascular constriction and proliferation. Nat. Med. 7: 693-698.
16. Durante, W., Kroll, M.H., Christodoulides, N., Peyton, K.J., and Schafer, A.I. 1997. Nitric oxide induces heme oxygenase-1 gene expression and carbon monoxide production in vascular smooth muscle cells. Circ. Res. 80: 557-564.
17. de Gaetano, G., and Collaborative Group of the Primary Prevention Project. 2001. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet, 357: 89-95.
18. Exner, M., Schillinger, M., Minar, E., Mlekusch, W., Schlerka, G., Haumer, M., Mannhalter, C., and Wagner, O. et al. 2001. Heme oxygenase-1 gene promoter microsatellite polymorphism is associated with restenosis after percutaneous transluminal angioplasty. J. Endovasc. Ther. 8: 433-440.
19. Ferris, C.D., Jaffrey, S.R., Sawa, A., Takahashi, M., Brady, S.D., Barrow, R.K., Tysoe, S.A., Wolosker, H., Baranano, D.E., Dore, S., Poss, K.D., and Snyder, S.H. et al. 1999. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1: 152-157.
20. Fogg, S., Agarwal, A., Nick, H.S., and Visner, G.A. 1999. Iron regulates hyperoxia-dependent human heme oxygenase 1 gene expression in pulmonary endothelial cells. Am. J. Respir. Cell Mol. Biol. 20: 797-804.
21. Furchgott, R.F., and Jothianandan, D. 1991. Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels, 28: 52-61.
22. GISSI-Prevenzione Investigators. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet, 354: 447-455.
23. Grundemar, L., Johansson, M.B., Ekelund, M., Hogestatt, E.D. 1995. Haem oxygenase activity in blood vessel homogenates as measured by carbon monoxide production. Acta Physiol. Scand. 153: 203-204.
24. Halliwell, B. 1994. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet, 344: 721-724.
25. Hansen, T.W., Mathiesen, S.B., and Walaas, S.I. 1996. Bilirubin has widespread inhibitory effects on protein phosphorylation. Pediatr. Res. 39: 1072-1077.
26. Hayashi, S., Takamiya, R., Yamaguchi, T., Matsumoto, K., Tojo, S.J., Tamatani, T., Kitajima, M., Makino, N., Ishimura, Y., and Suematsu, M. et al. 1999, Induction of heme oxygenase-1 suppresses venular leukocyte adhesion elicited by oxidative stress: role of bilirubin generated by the enzyme. Circ. Res. 85: 663-671.
27. Hoekstra, K.A., Godin, D.V., Kurtu, J., and Cheng, K.M. 2003a. Heme oxygenase and antioxidant status in cultured aortic endothelial cells isolated from atherosclerosis-susceptible and -resistant Japanese quail. Mol. Cell. Biochem. 252: 253-262.
28. Hoekstra, K.A., Godin, D.V., Kurtu, J., and Cheng, K.M. 2003b. Effect of oxidant-induced injury on heme oxygenase and glutathione in cultured aortic endothelial cells isolated from atherosclerosis-susceptible and -resistant Japanese quail. Mol. Cell. Biochem. 254: 61-71.
29. Hulea, S.A., Wasowicz, E., and Kummerow, F.A. 1995. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin. Biochim. Biophys. Acta, 1259: 29-38.
30. Ishikawa, K., Sato, M., Ito, M., and Yoshida, T. 1992. Importance of histidine residue 25 of rat heme oxygenase for its catalytic activity. Biochem. Biophys. Res. Commun. 182: 981-986.
31. Ishikawa, K., Navab, M., Leitinger, N., Fogelman, A.M., and Lusis, A.J. 1997. Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. J. Clin. Invest. 100: 1209-1216.
32. Ishikawa, K., Matera, K.M., Zhou, H., Fujii, H., Sato, M., et al. 1998. Identification of histidine 45 as the axial heme iron ligand of heme oxygenase-2. J. Biol. Chem. 273: 4317-4322.
33. Ishikawa, K., Sugawara, D., Goto, J., Watanabe, Y., Kawamura, K., Shiomi, M., Itabe, H., and Maruyama, Y et al. 2001a. Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation, 104: 1831-1836.
34. Ishikawa, K., Sugawara, D., Wang, X.P., Suzuki, K., Itabe, H., Maruyama, Y., and Lusis, AJ. 2001b. Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice. Circ. Res. 88: 506-512.
35. Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G.M., Eaton, J.W., and Balla, G. 2002. Pro-oxidant and cytotoxic effects of circulating heme. Blood, 100: 879-887.
36. Juan, S.H., Lee, T.S., Tseng, K.W., Liou, J.Y., Shyue, S.K., Wu, K.K., and Chau, L.Y 2001. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation, 104: 1519-1525.
37. Kaide, J.I., Zhang, F., Wei, Y., Jiang, H., Yu, C., et al. 2001. Carbon monoxide of vascular origin attenuates the sensitivity of renal arterial vessels to vasoconstrictors. J. Clin. Invest. 107: 1163-1171.
38. Kawashima, A., Oda, Y., Yachie, A., Koizumi, S., and Nakanishi, I. 2002. Heme oxygenase-1 deficiency: the first autopsy case. Hum. Pathol. 33: 125-130.
39. Keaney, J.F., Jr., and Vita, J.A. 1995. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog. Cardiovasc. Dis. 38: 129-154.
40. Keyse, S.M., and Tyrrell, R.M. 1989. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc. Nat. Acad. Sci. U.S.A. 86: 99-103.
41. Keyse, S.M., and Tyrrell, R.M. 1990. Induction of the heme oxygenase gene in human skin fibroblasts by hydrogen peroxide and UVA (365 nm) radiation: evidence for the involvement of the hydroxyl radical. Carcinogenesis, 11: 787-791.
42. Kozma, F., Johnson, R.A., Zhang, F., Yu, C., Tong, X., and Nasjletti, A. 1999. Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels. Am. J. Physiol. 276: R1087-R1094.
43. Kume, N., Arai, H., Kawai, C., and Kita, T. 1991. Receptors for modified low-density lipoproteins on human endothelial cells: different recognition for acetylated low-density lipoprotein and oxidized low-density lipoprotein. Biochim. Biophys. Acta, 1091: 63-67.
44. Kutty, R.K., and Maines, M.D. 1984. Hepatic heme metabolism: possible role of biliverdin in the regulation of heme oxygenase activity. Biochem. Biophys. Res. Commun. 122: 40-46.
45. Kwak, J.Y., Takeshige, K., Cheung, B.S., and Minakami, S. 1991. Bilirubin inhibits the activation of superoxide-producing NADPH oxidase in a neutrophil cell-free system. Biochem. Biophys. Acta, 1076: 369-373.
46. Lavrovsky, Y., Schwartzman, M.L., Levere, R.D., Kappas, A., and Abraham, N.G. 1994. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. U.S.A. 91: 5987-5991.
47. Lee, P.J., Jiang, B.H., Chin, B.Y., Iyer, N.V., Alam, J., Semenza, G.L., and Choi, A.M. 1997. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia.. J. Biol. Chem. 272: 5375-5381.
48. Leffler, C., Nasjletti, A., Yu, C., Johnson, R.A., Fedinec, A.L., and Walker, N. 1999. Carbon monoxide and cerebral microvascular tone in newborn pigs. Am. J. Physiol. 276: H1641-H1646.
49. Liu, X.M., Chapman, G.B., Peyton, K.J., Schafer, A.I., and Durante, W. 2002. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Cardiovasc. Res. 55: 396-405.
50. McCoubrey, W.K., Jr., and Maines, M.D. 1994. The structure, organization and differential expression of the gene encoding rat heme oxygenase-2. Gene, 139: 155-161.
51. McCoubrey, W.K., Jr., Huang, T.J., and Maines, M.D. 1997. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur. J. Biochem. 247: 725-732.
52. Maines, M.D. 1997. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37: 517-554.
53. Maines, M.D., and Kappas, A. 1974. Cobalt induction of hepatic heme oxygenase; with evidence that cytochrome P-450 is not essential for this enzyme activity. Proc. Natl. Acad. Sci. U.S.A. 71: 4293-4297.
54. Maines, M.D., and Kappas, A. 1977. Regulation of heme pathway enzymes and cellular glutathione content by metals that do not chelate with tetrapyrroles: blockade of metal effects by thiols. Proc. Natl. Acad. Sci. U.S.A. 74: 1875-1878.
55. Marks, O.S., Brien, J.F., Nakatsu, K., and McLaughlin, B.E. 1991. Does carbon monoxide have a physiological function? Trends Pharmacol. Sci. 12: 185-188.
56. Mayer, M. 2000. Association of serum bilirubin concentration with risk of coronary artery disease. Clin. Chem. 46: 1723-1727.
57. Melo, L.G., Agrawal, R., Zhang, L., Rezvani, M., Mangi, A.A., Ehsan, A., Griese, D.P., Dell'Acqua, G., Mann, M.J., Oyama, J., Yet, S.F., Layne, M.D., Perrella, M.A., and Dzau, V.J. et al. 2002. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation, 105: 602-607.
58. Mireles, L.C., Lum, M.A., and Dennery, P.A. 1999. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr. Res. 45: 355-362.
59. Motterlini, R., Gonzales, A., Foresti, R., Clark, J.E., Green, C.J., and Winslow, R.M. 1998. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ. Res. 83: 568-577.
60. Muller-Eberhard, U., and Fraig, M. 1993. Bioactivity of heme and its containment. Am. J. Hematol. 42: 59-62.
61. Nakagami, T., Toyomura, K., Kinoshita, T., and Morisawa, S. 1993. A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin. Biochim. Biophys. Acta, 1158: 189-193.
62. Navab, M., Berliner, J.A., Watson, A.D., Hama, S.Y., Territo, M.C., et al. 1996. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler. Thromb. Vasc. Biol. 16: 831-842.
63. Neuzil, J., and Stocker, R. 1994. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J. Biol. Chem. 269: 16712-16719.
64. Oberle, S., Abate, A., Grosser, N., Vreman, H.J., Dennery, P.A., Schneider, H.T., Stalleicken, D., and Schroder, H. et al. 2002. Heme oxygenase-1 induction may explain the antioxidant profile of pentaerithrityl trinitrate. Biochem. Biophys. Res. Commun. 290: 1539-1544.
65. Otterbein, L.E., Bach, F.H., Alam, J., Soares, M., Tao, H., Wysk, M., Davis, R.J., Flavell, R.A., and Choi, A.M. et al. 2000. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 6: 422-428.
66. Pang, J.H., Jiang, M.J., Chen, Y.L., Wang, F.W., Wang, D.L., Chu, S.H., and Chau, L.Y. 1996. Increased ferritin gene expression in atherosclerotic lesions. J. Clin. Invest. 97: 2204-2212.
67. Parhami, F., Fang, Z.T., Fogelman, A.M., Andalibi, A., Territo, M.C., and Berliner, J.A. 1993. Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J. Clin. Invest. 92: 471-478.
68. Peluzio, M.C., Homem, A.P., Cesar, G.C., Azevedo, G.S., Amorim, R., et al. 2001. Influences of alpha-tocopherol on cholesterol metabolism and fatty streak development in apolipoprotein E-deficient mice fed an atherogenic diet. Braz. J. Med. Biol. Res. 34: 1539-1545.
69. Peyton, K.J., Reyna, S.V., Chapman, G.B., Ensenat, D., Liu, X.M., et al. 2002. Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth. Blood, 99: 4443-4448.
70. Pitas, R.E. 1990. Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. Upregulation by phorbol esters. J. Biol. Chem. 265: 12722-12 727.
71. Polte, T., Abate, A., Dennery, P.A., and Schroder, H. 2000. Heme oxygenase-1 is a cyclic GMP-inducible endothelial protein and mediates the cytoprotective action of nitric oxide. Arterioscler. Thromb. Vasc. Biol. 20: 1209-1215.
72. Poss, K.D., and Tonegawa S. 1997a. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. U.S.A. 94: 10 925-10 930.
73. Poss, K.D., and Tonegawa, S. 1997b. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 94: 10919-10924.
74. Quan, S., Yang, L., Abraham, N.G., and Kappas, A. 2001. Regulation of human heme oxygenase in endothelial cells by using sense and antisense retroviral constructs. Proc. Natl. Acad. Sci. U.S.A. 98: 12 203-12 208.
75. Reif, D.W. 1992. Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 12: 417-427.
76. Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London), 362: 801-809.
77. Sammut, I.A., Foresti, R., Clark, J.E., Exon, D.J., Vesely, M.J., et al. 1998. Carbon monoxide is a major contributor to the regulation of vascular tone in aortas expressing high levels of haeme oxygenase-1. Br. J. Pharmacol. 125: 1437-1444.
78. Sardana, M.K., Drummond, G.S., Sassa, S., and Kappas, A. 1981. The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology, 23: 247-253.
79. Sardana, M.K., Sassa, S., and Kappas, A. 1982. Metal ion-mediated regulation of heme oxygenase induction in cultured avian liver cells. J. Biol. Chem. 257: 4806-4811.
80. Selmeci, L., Antal, M., Horkay, F., Merkely, B., Szokodi, I., et al. 2000. Enhanced accumulation of pericardial fluid ferritin in patients with coronary artery disease. Coron. Artery Dis. 11: 53-56.
81. Shibahara, S., Yoshida, T., and Kikuchi, G. 1979. Mechanism of increase of heme oxygenase activity induced by hemin in cultured pig alveolar macrophages. Arch. Biochem. Biophys. 197: 607-617.
82. Shibahara, S., Yoshizawa, M., Suzuki, H., Takeda, K., Meguro, K., and Endo, K. 1993. Functional analysis of cDNAs for two types of human heme oxygenase and evidence for their separate regulation. J. Biochem. (Tokyo) 113: 214-218.
83. Snyder, S.H., and Baranano, D.E. 2001. Heme oxygenase: a font of multiple messengers. Neuropsychopharmacology, 25: 294-298.
84. Steinberg, D. 1991. Antioxidants and atherosclerosis. A current assessment. Circulation, 84: 1420-1425.
85. Steinberg, D. 1995. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing? Lancet, 346: 36-38.
86. Stephens, N.G., Parsons, A., Schofield, P.M., Kelly, F., Cheeseman, K., and Mitchinson, M.J. 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet, 347: 781-786.
87. Stocker, R. 1990. Induction of haem oxygenase as a defense against oxidative stress. Free Radic. Res. Commun. 9: 101-112.
88. Stocker, R., Yamamoto, Y., McDonagh, A.F., Glazer, A.N., and Ames, B.N. 1987. Bilirubin is an antioxidant of possible physiological importance. Science (Washington, D.C.), 235: 1043-1046.
89. Stroes, E.S., Koomans, H.A., de Bruin, T.W., and Rabelink, T.J. 1995. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet, 346: 467-471.
90. Taketani, S., Kohno, H., Yoshinaga, T., and Tokunaga, R. 1988. Induction of heme oxygenase in rat hepatoma cells by exposure to heavy metals and hyperthermia. Biochemistry, 17: 665-672.
91. Tenhunen, R., Marver, H.S., and Schmid, R. 1968. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A. 61: 748-755.
92. Tenhunen, R., Marver, H.S., and Schmid, R. 1969a. Microsomal heme oxygenase. Characterization of the enzyme. J. Biol. Chem. 244: 6388-6394.
93. Tenhunen, R., Marver, H.S., and Schmid, R. 1969b. The enzymatic conversion of hemoglobin to bilirubin. Trans. Assoc. Am. Physicians 82: 363-371.
94. Tulis, D.A., Durante, W., Liu, X., Evans, A.J., Peyton, K.J., and Schafer, A.I. 2001. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation, 104: 2710-2715.
95. Verma, A., Hirsch, D.J., Glatt, C.E., Ronnett, G.V., and Snyder, S.H. 1993. Carbon monoxide: a putative neural messenger. Science (Washington, D.C.), 259: 381-384.
96. Vile, G.F., and Tyrrell, R.M. 1993. Oxidative stress resulting from ultraviolet A irradiation of human skin fibroblasts leads to a heme oxygenase-dependent increase in ferritin. J. Biol. Chem. 268: 14678-14681.
97. Wagner, C.T., Durante, W., Christodoulides, N., Hellums, J.D., and Schafer, A.I. 1997. Hemodynamic forces induce the expression of heme oxygenase in cultured vascular smooth muscle cells. J. Clin. Invest. 100: 589-596.
98. Wang, L.J., Lee, T.S., Lee, F.Y., Pai, R.C., and Chau, L.Y. 1998. Expression of heme oxygenase-1 in atherosclerotic lesions. Am. J. Pathol. 152: 711-20.
99. Willis, D., Tomlinson, A., Frederick, R., Paul-Clark, M.J., and Willoughby, D.A. 1995. Modulation of heme oxygenase activity in rat brain and spleen by inhibitors and donors of nitric oxide. Biochem. Biophys. Res. Commun. 214: 1152-1156.
100. Willis, D., Moore, A.R., Frederik, R., and Willoughby, D.A. 1996. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nat. Med. 2: 87-90.
101. Witztum, J.L., and Steinberg, D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88: 1785-1792.
102. Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., et al. 1999. Oxidative stress causes enhanced endothelial cell injury in human gene oxygenase-1 deficiency. J. Clin. Invest. 103: 129-135.
103. Yamada, N., Yamaya, M., Okinaga, S., Nakayama, K., Sekizawa, K., Shibahara, S., and Sasaki, H. 2000. Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema. Am. J. Hum. Genet. 66: 187-195.
104. Yamaguchi, M., Sato, H., and Bannai, S. 1993. Induction of stress proteins in mouse peritoneal macrophages by oxidized low-density lipoprotein. Biochem. Biophys. Res. Commun. 193: 1198-1201.
105. Yee, E.L., Pitt, B.R., Billiar, T.R., and Kim, Y.M. 1996. Effect of nitric oxide on heme metabolism in pulmonary artery endothelial cells. Am. J. Physiol. 271: L512-L518.
106. Yet, S.F., Layne, M.D., Liu, X., Chen, Y.H., Ith, B., Sibinga, N.B., and Perrella, M. A. 2003. Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling. FASEB J. 17: 1759-1761.
107. Yusuf, S., Dagenais, G., Pogue, J., Bosch, J., and Sleight, P. 2000. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342: 154-160.
108. Zhang, S.H., Reddick, R.L., Avdievich, E., Surles, L.K., Jones, R.G., et al. 1997. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice. J. Clin. Invest. 99: 2858-2866.